Company page

Response Genetics Inc

Response Genetics Inc (ticker: RGDXQ) is a public company based in the United States with a market capitalization of approximately $77.59 million. The company specializes in genetic testing and diagnostics, focusing on cancer-related services. Its innovative approach aims to improve patient outcomes through personalized medicine.